163 related articles for article (PubMed ID: 17621367)
61. Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma.
Yasunaga JI
Int J Hematol; 2023 Apr; 117(4):504-511. PubMed ID: 36705848
[TBL] [Abstract][Full Text] [Related]
62. HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis.
Matsuoka M
Mol Aspects Med; 2010 Oct; 31(5):359-66. PubMed ID: 20599553
[TBL] [Abstract][Full Text] [Related]
63. Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.
Chan CP; Kok KH; Jin DY
Adv Exp Med Biol; 2017; 1018():147-166. PubMed ID: 29052136
[TBL] [Abstract][Full Text] [Related]
64. HBZ and its roles in HTLV-1 oncogenesis.
Zhao T; Matsuoka M
Front Microbiol; 2012; 3():247. PubMed ID: 22787458
[TBL] [Abstract][Full Text] [Related]
65. Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription.
Younis I; Boris-Lawrie K; Green PL
J Virol; 2006 Jan; 80(1):181-91. PubMed ID: 16352542
[TBL] [Abstract][Full Text] [Related]
66. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.
Tomita M; Semenza GL; Michiels C; Matsuda T; Uchihara JN; Okudaira T; Tanaka Y; Taira N; Ohshiro K; Mori N
Biochem J; 2007 Sep; 406(2):317-23. PubMed ID: 17576198
[TBL] [Abstract][Full Text] [Related]
67. Dual effects of HTLV-1 bZIP factor in suppression of interferon regulatory factor 1.
Mukai R; Ohshima T
Biochem Biophys Res Commun; 2011 Jun; 409(2):328-32. PubMed ID: 21586271
[TBL] [Abstract][Full Text] [Related]
68. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.
Miyazaki M; Yasunaga J; Taniguchi Y; Tamiya S; Nakahata T; Matsuoka M
J Virol; 2007 Jun; 81(11):5714-23. PubMed ID: 17344291
[TBL] [Abstract][Full Text] [Related]
69. HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.
Takiuchi Y; Kobayashi M; Tada K; Iwai F; Sakurada M; Hirabayashi S; Nagata K; Shirakawa K; Shindo K; Yasunaga JI; Murakawa Y; Rajapakse V; Pommier Y; Matsuoka M; Takaori-Kondo A
Sci Rep; 2017 Oct; 7(1):12849. PubMed ID: 28993637
[TBL] [Abstract][Full Text] [Related]
70. Permissive Sense and Antisense Transcription from the 5' and 3' Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1.
Laverdure S; Polakowski N; Hoang K; Lemasson I
J Virol; 2016 Jan; 90(7):3600-10. PubMed ID: 26792732
[TBL] [Abstract][Full Text] [Related]
71. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis.
Ishikawa C; Nakachi S; Senba M; Sugai M; Mori N
Carcinogenesis; 2011 Jan; 32(1):110-9. PubMed ID: 20974684
[TBL] [Abstract][Full Text] [Related]
72. A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions.
Awasthi S; Sharma A; Wong K; Zhang J; Matlock EF; Rogers L; Motloch P; Takemoto S; Taguchi H; Cole MD; Lüscher B; Dittrich O; Tagami H; Nakatani Y; McGee M; Girard AM; Gaughan L; Robson CN; Monnat RJ; Harrod R
Mol Cell Biol; 2005 Jul; 25(14):6178-98. PubMed ID: 15988028
[TBL] [Abstract][Full Text] [Related]
73. HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.
Terol M; Gazon H; Lemasson I; Duc-Dodon M; Barbeau B; Césaire R; Mesnard JM; Péloponèse JM
Leukemia; 2017 Oct; 31(10):2235-2243. PubMed ID: 28260789
[TBL] [Abstract][Full Text] [Related]
74. HTLV-1 Alters T Cells for Viral Persistence and Transmission.
Tanaka A; Matsuoka M
Front Microbiol; 2018; 9():461. PubMed ID: 29615995
[TBL] [Abstract][Full Text] [Related]
75. Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism.
Bazarbachi A; Abou Merhi R; Gessain A; Talhouk R; El-Khoury H; Nasr R; Gout O; Sulahian R; Homaidan F; de Thé H; Hermine O; El-Sabban ME
Cancer Res; 2004 Mar; 64(6):2039-46. PubMed ID: 15026341
[TBL] [Abstract][Full Text] [Related]
76. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.
Robek MD; Wong FH; Ratner L
J Virol; 1998 May; 72(5):4458-62. PubMed ID: 9557741
[TBL] [Abstract][Full Text] [Related]
77. Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination.
Isono O; Ohshima T; Saeki Y; Matsumoto J; Hijikata M; Tanaka K; Shimotohno K
J Biol Chem; 2008 Dec; 283(49):34273-82. PubMed ID: 18805793
[TBL] [Abstract][Full Text] [Related]
78. Strategies of Human T-Cell Leukemia Virus Type 1 for Persistent Infection: Implications for Leukemogenesis of Adult T-Cell Leukemia-Lymphoma.
Yasunaga JI
Front Microbiol; 2020; 11():979. PubMed ID: 32508789
[TBL] [Abstract][Full Text] [Related]
79. [Molecular pathogenesis by human T-cell leukemia virus type 1].
Matsuoka M
Rinsho Ketsueki; 2011 May; 52(5):256-62. PubMed ID: 21646770
[No Abstract] [Full Text] [Related]
80. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Nakagawa M; Shaffer AL; Ceribelli M; Zhang M; Wright G; Huang DW; Xiao W; Powell J; Petrus MN; Yang Y; Phelan JD; Kohlhammer H; Dubois SP; Yoo HM; Bachy E; Webster DE; Yang Y; Xu W; Yu X; Zhao H; Bryant BR; Shimono J; Ishio T; Maeda M; Green PL; Waldmann TA; Staudt LM
Cancer Cell; 2018 Aug; 34(2):286-297.e10. PubMed ID: 30057145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
